A 40-year-old Caucasian woman presented with the history of neurofibromatosis type-1 (NF-1), diagnosed at age 5 years, with cutaneous neurofibromas on the face, back, and chest, and arachnoid cyst. Best-corrected visual acuity was 20/40 in the right eye and 20/20 in the left eye. Anterior segment examination revealed multifocal iris Lisch nodules in both eyes. Fundoscopic examination in the right eye revealed \[[Fig. 1a](#F1){ref-type="fig"}\] 3 areas of retinal microvascular tortuosity, including superonasal to the optic disc (white arrows, 6.0 mm by 3.0 mm), in the papillomacular bundle (yellow arrows 1.5 mm by 1.0 mm), and inferior to the macula (blue arrows, 2.0 by 2.0 mm). In the left eye \[[Fig. 1b](#F1){ref-type="fig"}\], there was 1 area of microvascular tortuosity in the papillomacular bundle (yellow arrows, 2.0 × 2.0 mm). Retinal microvascular tortuosity was confirmed on fundus autofluorescence imaging in the right \[[Fig. 1c](#F1){ref-type="fig"}\] and left \[[Fig. 1d](#F1){ref-type="fig"}\] eyes.
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By fluorescein angiography, areas of retinal microvascular tortuosity were visible \[[Fig. 2](#F2){ref-type="fig"}\] in each eye, without evidence of leakage, staining, or neovascularization.

![In the right eye, areas of retinal microvascular tortuosity were visible (A) superonasal to the optic disc (white arrows) and (B) inferior to the macula (blue arrows). (C) In the left eye, retinal microvascular tortuosity was observed in the papillomacular bundle (yellow arrows)](IJO-67-2054-g002){#F2}

Underlying the microvascular abnormalities were multiple hypopigmented choroidal lesions, suggestive of hamartoma, nevus, or neurofibroma. On OCT (vertical cut), these corresponded to \[[Fig. 3](#F3){ref-type="fig"}\] areas of increased choroidal density in the outer choroid (white arrow). Based on the benign retinal and choroidal findings, observation was advised.
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Retinal microvascular findings in NF-1 are likely congenital, representing defective migration of vasomotor nerve cells from the neural crest.\[[@ref1][@ref2][@ref3]\] These benign abnormalities remain stable over time without retinal ischemia, exudation, hemorrhage, vascular leakage, or visual acuity loss.\[[@ref1][@ref2][@ref3][@ref4]\] An analysis of 34 NF-1 patients demonstrated retinal microvasculature abnormalities (6/34) and choroidal nodules (23/34),\[[@ref4]\] while a larger cohort found no correlation of microvascular changes (18/294) with choroidal nodules (186/294) (*P* = 0.48).\[[@ref3]\] Our case exemplifies the subtle nature of microvascular abnormalities with underlying choroidal nodules in NF-1.
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